+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 50Years - 80Years
All Genders
Healthy Volunteers
ID05724264

Study of Low-Dose CT and Biomarker Testing for Lung Cancer Screening in Adults Aged 50 to 80 in Singapore

Led by National Cancer Centre, Singapore · Updated on 2026-05-15

1000

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the feasibility of using low dose CT LDCT screening combined with biomarker testing to detect lung cancer in at-risk populations in Singapore. The study focuses on both smokers and non-smokers with risk factors such as family history of lung cancer. This prospective, single-arm study aims to provide baseline data and validate risk factors to help inform future lung cancer screening guidelines specific to the local population. Participants will undergo LDCT scans, with results reported using the Lung CT Screening Reporting & Data System Lung-RADS. Based on their Lung-RADS score, participants will be grouped to guide follow-up care. Those with scores of 2 or higher will be referred for further clinical surveillance and diagnostic evaluation for up to five years. Participants with a score of 1 will have continued screening surveillance for two years if no nodules are detected. Blood samples and possibly urine, saliva, and breath samples will also be collected during screening and follow-up visits for biomarker analysis. During the study, detailed information on participant demographics, smoking history, environmental exposures, and medical history will be collected. Participants will be monitored with LDCT scans and biomarker testing over time to assess lung cancer detection rates, screening morbidity, and the utility of biomarker assays in improving LDCT performance. The primary outcome is the feasibility of LDCT screening over two years, with secondary outcomes including long-term biomarker utility and diagnostic accuracy. Participation may last up to seven years for some assessments.

CONDITIONS

Brief Title

SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)

Research Team

D

Darren Wan-Teck Lim, MD

G

Gillianne Geet-Yi Lai, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here